北京大学学报(医学版) ›› 2025, Vol. 57 ›› Issue (6): 1061-1066. doi: 10.19723/j.issn.1671-167X.2025.06.007

• 论著 • 上一篇    下一篇

以眼部病变首发的结节病的临床特征及预后

彭嘉婧, 崔莉*()   

  1. 首都医科大学附属北京同仁医院风湿免疫科,北京 100730
  • 收稿日期:2025-10-17 出版日期:2025-12-18 发布日期:2025-10-28
  • 通讯作者: 崔莉

Clinical features and prognosis of sarcoidosis with ocular lesions as the initial manifestation

Jiajing PENG, Li CUI*()   

  1. Department of Rheumatology and Immunology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
  • Received:2025-10-17 Online:2025-12-18 Published:2025-10-28
  • Contact: Li CUI

RICH HTML

  

摘要:

目的: 评估以眼部病变为首发表现的结节病的临床特征,并分析其治疗及预后情况。方法: 收集2010年7月至2025年7月首都医科大学附属北京同仁医院风湿免疫科的结节病患者的一般资料、临床表现、用药及治疗情况,并进行回顾性研究。结果: 23例患者中,男女比例为1 ∶ 2.3,平均年龄(45.1±14.1)岁,中位病程0.5(0.25,1.50)年,中位诊断时间0.5(0.20,1.00)年。以眼部病变首发的患者14例,以呼吸系统、关节肿痛等非眼部病变首发的患者9例。眼部病变中非感染性葡萄膜炎及眼眶肿物最常见,眼眶肿物患者多为泪腺肿大,其他表现包括视神经炎、视神经鞘膜炎等。中位随访时间21.21(5.00,147.29)个月,治疗后所有患者的临床症状都得到有效缓解,其中3例非感染性葡萄膜炎患者及1例视神经鞘膜炎患者的视力指标较治疗前好转,视功能得到改善。随访阶段内,2例结节病患者出现病情复发,经重新制定治疗方案并实施治疗后,患者病情均获得缓解,预后良好。眼部病变首发的患者与非眼部病变首发的患者相比,眼部病变首发组患者诊断用时更长,差异有统计学意义(P=0.025)。眼部病变首发组患者C反应蛋白(C-reactive protein, CRP)为1.90(0.50, 4.62) mg/L,非眼部病变首发组CRP为11.70(0.90, 31.45) mg/L,差异有统计学意义(P=0.042)。眼部病变首发组患者红细胞沉降率(erythrocyte sedimentation rate, ESR)为14.00(8.50, 24.00) mm/h,非眼部病变首发组ESR为26.00(15.50, 47.00) mm/h,差异有统计学意义(P=0.033),眼部病变首发组CRP及ESR均较非眼部病变首发组更低。结论: 对于眼部病变首发的结节病患者,临床诊断往往存在挑战,常规炎症指标难以有效提示病情,易被忽略,故提升临床医师对结节病眼部首发特征的识别能力是实现早期诊断、开展及时治疗的关键。

关键词: 结节病, 非感染性葡萄膜炎, 泪腺肿大

Abstract:

Objective: To evaluate the clinical features of sarcoidosis with ocular lesions as the initial manifestation and to analyze its treatment and prognostic outcomes. Methods: A retrospective study was conducted to evaluate the clinical data of sarcoidosis patients from July 2010 to July 2025 in the Department of Rheumatology and Immunology, Beijing Tongren Hospital. Results: Among the 23 patients, the male-to-female ratio was 1 ∶ 2.3, with a mean age of (45.1±14.1) years, a median disease duration of 0.5 (0.25, 1.50) years, and a median diagnosis time of 0.5 (0.20, 1.00) years. Fourteen patients presented with ocular lesions as the initial manifestations, while 9 patients had non-ocular lesions (such as respiratory system involvement or joint swelling/pain) as the initial manifestations. The most common ocular lesions were non-infectious uveitis and orbital masses. Orbital masses were most commonly encountered as lacrimal gland enlargement. Other ocular lesions included optic neuritis and optic perineuritis. The median follow-up time was 21.21 (5.00, 147.29) months. Following treatment, all the patients achieved significant clinical improvement, of whom 3 patients with non-infectious uveitis and 1 with optic perineuritis showed improved visual acuity and overall visual function. During the follow-up period, 2 patients with sarcoidosis experienced disease recurrence. After their treatment regimens were reinitiated, both patients achieved remission with a favorable prognosis. Compared with the patients with non-ocular-onset as the initial manifestation, the patients with ocular-onset as the initial manifestation had a significantly longer diagnosis time, and the difference was statistically significant (P =0.025). The C-reactive protein (CRP) level was 1.90 (0.50, 4.62) mg/L in the ocular-onset group and 11.70 (0.90, 31.45) mg/L in the non-ocular-onset group, and the difference was statistically significant (P =0.042). The erythrocyte sedimentation rate (ESR) was 14.00 (8.50, 24.00) mm/h in the ocular-onset group and 26.00 (15.50, 47.00) mm/h in the non-ocular-onset group, and the difference was statistically significant (P =0.033). The ocular-onset group had significantly lower levels of both CRP and ESR compared with the non-ocular-onset group. Conclusion: Sarcoidosis with ocular-onset as the initial manifestation poses diagnostic challenges, as routine inflammatory markers have limited utility in suggesting the disease and thus it is easily overlooked. Therefore, enhancing clinicians' ability to recognize these ocular-onset features is crucial for achieving early diagnosis and enabling timely intervention.

Key words: Sarcoidosis, Non-infectious uveitis, Lacrimal gland enlargement

中图分类号: 

  • R593.2

图1

结节病双眼非感染性葡萄膜炎眼底荧光造影"

图2

结节病泪腺肿大眼眶磁共振成像"

图3

结节病视神经鞘膜炎眼眶磁共振成像"

表1

眼部病变首发和非眼部病变首发的结节病患者临床特征"

Items Ocular-onset (n=14) Non-ocular-onset (n=9) P value
Female, n(%) 7 (50) 9 (100) 0.019
Age/years, $\bar x \pm s$ 45.00±15.84 45.22±11.71 0.972
Age of onset/years, $\bar x \pm s$ 42.54±15.22 44.68±11.57 0.722
CRP/(mg/L), M (P25P75) 1.90 (0.50, 4.62) 11.70 (0.90, 31.45) 0.042
ESR/(mm/h), M (P25P75) 14.00 (8.50, 24.00) 26.00 (15.50, 47.00) 0.033
ACE/(U/L), $\bar x \pm s$ 37.36±18.33 44.33±24.95 0.448
IgG/(mg/dL), $\bar x \pm s$ 1 196.48±249.65 1 283.44±395.03 0.544
IgA/(mg/dL), $\bar x \pm s$ 218.69±107.86 275.86±127.95 0.281
IgM/(mg/dL), $\bar x \pm s$ 103.64±43.97 135.76±56.38 0.158
Complement C3/(mg/dL), $\bar x \pm s$ 110.08±31.11 134.39±25.73 0.077
Complement C4/(mg/dL), $\bar x \pm s$ 27.34±11.23 31.02±7.46 0.412
Duration/years, M (P25P75) 1.00 (0.36, 4.25) 0.50 (0.23, 0.75) 0.092
Time to diagnosis/years, M (P25P75) 1.00 (0.36, 1.50) 0.20 (0.10, 0.75) 0.025
Follow-up time/months, M (P25P75) 24.23 (2.78, 148.42) 12.54 (10.15, 122.34) 0.801
1
Arkema EV , Cozier YC . Sarcoidosis epidemiology: Recent estimates of incidence, prevalence and risk factors[J]. Curr Opin Pulm Med, 2020, 26 (5): 527- 534.

doi: 10.1097/MCP.0000000000000715
2
Iannuzzi MC , Rybicki BA , Teirstein AS . Sarcoidosis[J]. N Engl J Med, 2007, 357 (21): 2153- 2165.

doi: 10.1056/NEJMra071714
3
中华医学会呼吸病学分会间质性肺疾病学组, 中国医师协会呼吸医师分会间质性肺疾病工作委员会. 中国肺结节病诊断和治疗专家共识[J]. 中华结核和呼吸杂志, 2019, 42 (9): 685- 693.
4
Besnier ME . Synovites fongueuses (scrofulo-tuberculeuses) symétriques des extrémités supérieures[J]. Ann Dermatol Syphiligr (Paris), 1889, 10, 333- 336.
5
Rybicki BA , Major M , Popovich J Jr , et al. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization[J]. Am J Epidemiol, 1997, 145 (3): 234- 241.

doi: 10.1093/oxfordjournals.aje.a009096
6
Haimovic A , Sanchez M , Judson MA , et al. Sarcoidosis: A comprehensive review and update for the dermatologist: Part Ⅰ. Cutaneous disease[J]. J Am Acad Dermatol, 2012, 66 (5): 699.e1- 699.18; quiz 717-778.

doi: 10.1016/j.jaad.2011.11.965
7
Adrianto I , Lin CP , Hale JJ , et al. Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility[J]. PLoS One, 2012, 7 (8): e43907.

doi: 10.1371/journal.pone.0043907
8
Meguro A , Ishihara M , Petrek M , et al. Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis[J]. Commun Biol, 2020, 3 (1): 465.

doi: 10.1038/s42003-020-01185-9
9
Li QH , Zhang Y , Zhao MM , et al. Simultaneous amplification and testing method for Mycobacterium tuberculosis rRNA to differentiate sputum-negative tuberculosis from sarcoidosis[J]. Am J Physiol Lung Cell Mol Physiol, 2019, 316 (3): L519- L524.

doi: 10.1152/ajplung.00172.2018
10
Lee H , Eom M , Kim SH , et al. Identification of Mycobacterium tuberculosis and non-Tuberculous mycobacteria from Cutaneous sarcoidosis lesions by reverse blot hybridization assay[J]. J Dermatol, 2019, 46 (10): 917- 921.

doi: 10.1111/1346-8138.15042
11
Negi M , Takemura T , Guzman J , et al. Localization of pro-pionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium[J]. Mod Pathol, 2012, 25 (9): 1284- 1297.

doi: 10.1038/modpathol.2012.80
12
Ishige I , Usui Y , Takemura T , et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis[J]. Lancet, 1999, 354 (9173): 120- 123.

doi: 10.1016/S0140-6736(98)12310-3
13
Eishi Y . Etiologic link between sarcoidosis and Propionibacterium acnes[J]. Respir Investig, 2013, 51 (2): 56- 68.

doi: 10.1016/j.resinv.2013.01.001
14
He D , Tao T , Peng X , et al. Prevalence and clinical characteristics of ocular sarcoidosis among non-infectious uveitis in a Chinese tertiary ophthalmic center: A retrospective observational study[J]. BMC Ophthalmol, 2025, 25 (1): 386.

doi: 10.1186/s12886-025-04165-x
15
Herbort CP , Rao NA , Mochizuki M . International criteria for the diagnosis of ocular sarcoidosis: Results of the first International Workshop on Ocular Sarcoidosis (IWOS)[J]. Ocul Immunol Inflamm, 2009, 17 (3): 160- 169.

doi: 10.1080/09273940902818861
16
Mochizuki M , Smith JR , Takase H , et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis[J]. Br J Ophthalmol, 2019, 103 (10): 1418- 1422.

doi: 10.1136/bjophthalmol-2018-313356
17
Reich JM . Corticosteroid therapy and relapse in sarcoidosis[J]. Chest, 1998, 113 (2): 559- 560.
[1] 刘源, 石桂秀. 干燥综合征到干燥病的命名变迁[J]. 北京大学学报(医学版), 2025, 57(6): 1015-1017.
[2] 练益瑞, 刘静璇, 赵亮, 赵静, 臧思田, 李玉慧. 抗PM/Scl抗体相关风湿性疾病谱及其在特发性炎性肌病中的免疫学特征[J]. 北京大学学报(医学版), 2025, 57(6): 1018-1023.
[3] 吴滔, 林建子, 朱亚锋, 马剑达, 贾霈雯, 杨莉娟, 潘婕, 邹耀威, 杨迎, 卢烨, 戴冽. 血清蛋白质谱筛选及验证类风湿关节炎患者肌肉量减少的生物标志物[J]. 北京大学学报(医学版), 2025, 57(6): 1024-1031.
[4] 林文灏, 谢阳, 王芳晴, 王淑盈, 刘香君, 胡凡磊, 贾园. 基于B细胞单细胞转录组测序的干燥综合征分子分型[J]. 北京大学学报(医学版), 2025, 57(6): 1032-1041.
[5] 向钊, 杨莉, 杨静. 非靶向代谢组学揭示原发性干燥综合征血小板减少患者血清差异代谢物及代谢通路[J]. 北京大学学报(医学版), 2025, 57(6): 1042-1050.
[6] 赵亚云, 倪梦凡, 李雪, 王蓓, 程功, 何菁, 金月波. 利妥昔单抗治疗原发性干燥综合征肾损害的临床疗效和安全性[J]. 北京大学学报(医学版), 2025, 57(6): 1051-1060.
[7] 高雅静, 李正芳, 马梦思, 武丽君. SII和SIRI对白塞病葡萄膜炎的风险预测及疾病活动度和预后的评估[J]. 北京大学学报(医学版), 2025, 57(6): 1067-1073.
[8] 王晓林, 郭邵逸, 陈大召, 温锡杰, 华勇, 张亮, 张秦. 全髋关节置换术治疗系统性红斑狼疮继发股骨头缺血性坏死的随访研究[J]. 北京大学学报(医学版), 2025, 57(6): 1081-1088.
[9] 吴昕峰, 满斯亮, 陈大召, 华勇, 温锡杰, 丁盈月, 张亮, 侯秀娟. 中轴型脊柱关节炎合并髋关节终末期受累的长期影像学参数:单中心24年大样本回顾研究[J]. 北京大学学报(医学版), 2025, 57(6): 1089-1095.
[10] 兰静雯, 陈哲, 程永静, 赵丽珂. 老年结缔组织病相关间质性肺病临床特征及抗纤维化治疗的疗效和安全性[J]. 北京大学学报(医学版), 2025, 57(6): 1101-1106.
[11] 李岩岩, 刘香君, 李公明, 李春, 贾园. 抗磷脂综合征患者就医行为及治疗现状调查[J]. 北京大学学报(医学版), 2025, 57(6): 1107-1112.
[12] 卫春, 杨月, 赵新菊, 刘栩, 贾园. 系统性红斑狼疮合并自身免疫性郎飞结病1例[J]. 北京大学学报(医学版), 2025, 57(6): 1174-1179.
[13] 董琪, 何菁, 贾园, 姚海红, 张霞. 模拟复发性多软骨炎的VEXAS综合征1例[J]. 北京大学学报(医学版), 2025, 57(6): 1180-1183.
[14] 赵凯, 鲁芙爱, 王永福. 中枢神经系统感染模拟神经精神狼疮1例[J]. 北京大学学报(医学版), 2025, 57(6): 1188-1192.
[15] 吕雪冰, 俞烜华, 张伟桢, 刘昌泉, 林互涵, 曾珊婷, 黄惠娟, 吴月萍. 类风湿关节炎合并坏死性筋膜炎1例[J]. 北京大学学报(医学版), 2025, 57(6): 1198-1202.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!